Robert Nelsen is a founder and venture capitalist focused on disruptive innovation in biotechnology. He actively invests as an angel in technology startups and promotes advancements in AI-driven drug discovery. Nelsen is recognized for his expertise in biotech innovation and public health, leveraging his leadership to support transformative medicines and technology ventures.

‌